FDA Issues Warning Letter to Center For Immunology Science
January 28, 2026
January 28, 2026
WASHINGTON, Jan. 28 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Center For Immunology Science LLC from the Center for Drug Evaluation and Research:
* * *
Recipient: Bruce S. Gillis, M.D., MPH, CEO, Center For Immunology Science, LLC, 2109 Granville Avenue, Los Angeles, CA 90025-6105, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
* * *
Recipient: Bruce S. Gillis, M.D., MPH, CEO, Center For Immunology Science, LLC, 2109 Granville Avenue, Los Angeles, CA 90025-6105, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
